In this issue:
A critical overview of delusion in schizophrenia research
Cost and health impacts of adherence to the NICE schizophrenia guideline recommendations
Clozapine vs olanzapine vs haloperidol in the treatment of violence in schizophrenia with and without conduct disorder
Dementia diagnoses among older US adults with schizophrenia
Short-acting intramuscular second-generation antipsychotic drugs for acutely agitated patients with schizophrenia spectrum disorders
Prednisolone vs placebo addition in recent-onset psychotic disorder
Evaluation of the use of clozapine in the UK
Functional benefits of co-occurring autistic symptoms in schizophrenia is delimited by symptom severity
Treatment resistance and prolonged length of stay among schizophrenia inpatients in forensic institutions
Depression in first-episode schizophrenia spectrum disorders
Please login below to download this issue (PDF)